Sorrento Therapeutics, at work on a nanoparticle successor to the blockbuster cancer drug Abraxane, said its candidate is coming through in an ongoing Phase III trial. And while the biotech declined to get into specific details, the whiff of success sent its shares up more than 10% on Monday.
At the Children's Hospital of Philadelphia, researchers are looking toward biodegradable nanoparticles capable of delivering cancer drugs to neuroblastoma without harming surrounding tissue.
A team of researchers is developing a new form of microbubble delivery, deploying ultrasound to implode the bubbles into several smaller nanobubbles that can cross biological barriers due to their size and release the payloads within the target area.
Bypassing the traditional delivery technologies for antibiotics, European investigators say they successfully tested the use of nanoparticles in delivering antibiotics for respiratory infections, slipping through biological barriers and zeroing in better on the target.
A team of MIT scientists has designed a new injectable hydrogel made from nanoparticles that could someday be used to hold drugs in the body, treating diseases such as cancer, macular degeneration and heart disease.
Google is developing a wearable medical device consisting of a magnet that would collect ingested nanoparticles whose job it is to attach to cancerous cells and take them to the magnet. The nanoparticles convey data to the magnet by "lighting up" cancer cells, Andrew Conrad, the head of Google's life sciences unit, said.
Researchers at the University of Maryland and Bethesda, MD-based Weinberg Medical Physics have created a startup called Iron Focus Medical that attempts to build on their prior research to commercialize a novel drug delivery system.
A Purdue University team has created a new chip that promises to help test how cancer-killing nanoparticles react in a tumor environment. Because different nanoparticles perform vastly different functions in drug delivery, it's important to determine early on what kind of effect they will have on a tumor and what it would take to improve their outcome.
Researchers at the Institute of General Physics at the Russian Academy of Sciences and the Moscow Institute of Physics and Technology said their advancement in biocomputing using nanoparticles is a step towards creating drug-delivering nanorobots.
A bioengineering professor says he has developed nanoparticles that can carry cancer-fighting insect toxins directly to tumors, sparing the rest of the body from nasty side effects, including damage to the heart, bleeding underneath the skin and unwanted clotting.